Mark Thursz

Active 1993–2025

155
Papers
18,466
Citations
80
h-index
147
i10-index

Citations

Citations per year for Mark Thursz1986: 1 citations1995: 3 citations1996: 11 citations1997: 14 citations1998: 26 citations1999: 29 citations2000: 29 citations2001: 40 citations2002: 43 citations2003: 48 citations2004: 53 citations2005: 66 citations2006: 58 citations2007: 45 citations2008: 50 citations2009: 55 citations2010: 66 citations2011: 43 citations2012: 55 citations2013: 55 citations2014: 42 citations2015: 80 citations2016: 103 citations2017: 91 citations2018: 126 citations2019: 564 citations2020: 805 citations2021: 1,047 citations2022: 829 citations2023: 602 citations2024: 916 citations2025: 430 citations2026: 13 citations1987–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,848 citing papers, 18.8% of this breakdownChina: 1,104 citing papers, 11.3% of this breakdownUnited Kingdom: 966 citing papers, 9.8% of this breakdownGermany: 417 citing papers, 4.3% of this breakdownFrance: 393 citing papers, 4% of this breakdownItaly: 387 citing papers, 3.9% of this breakdownSpain: 385 citing papers, 3.9% of this breakdownCanada: 305 citing papers, 3.1% of this breakdownAustralia: 286 citing papers, 2.9% of this breakdownNetherlands: 203 citing papers, 2.1% of this breakdownJapan: 198 citing papers, 2% of this breakdownSwitzerland: 195 citing papers, 2% of this breakdown
0%18.8%Other 31.9%

Fields

  • Medicine71.7%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology6.4%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Engineering1.4%
  • Agricultural and Biological Sciences0.9%
  • Other4.5%

Topics

  • Liver Disease Diagnosis and Treatment10.6%
  • Hepatitis C virus research6.1%
  • Hepatitis B Virus Studies5.4%
  • Alcohol Consumption and Health Effects4.2%
  • Liver Disease and Transplantation3.9%
  • Gut microbiota and health3.2%
  • Other66.6%

Coauthors

All papers

Open in search
  1. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

    Authors: , , , , , , , - Journal of Hepatology 2018 cited by 913

  2. Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2020 cited by 404

  3. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

    Authors: , , , , , , , , , , , , , , , - Gut 2019 cited by 195

  4. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Z. Wiktor, Ayman A. Abdo, Rakesh Aggarwal, Alessio Aghemo, Bandar Al‐Judaibi, Mamun Al Mahtab, Arshad Altaf, Zyaad Ameen, Tarik Asselah, Oidov Baatarkkhuu, Ella Barber, Eleanor Barnes, Pascale Boulet, Louise Burrows, Maia Butsashvili, Erica On-Ting Chan, Chelsea Chow, Ben Cowie, Chris Cunningham, Alexandre de Araújo, Graciela Diap, Gregory J. Dore, Joseph Doyle, Manal H. El‐Sayed, Emmanuel Fajardo, Ed Gane, Aneley Getahun, David Goldberg, Tiffany Got, Matthew Hickman, Andrew Hill, Sharon Hutchinson, Christopher R. Jones, Saleem Kamili, Amreen Khan, Alice Lee, Tin Yan Lee, Jioiji Malani, Tammy Meyers-Morris, Shevanthi Nayagam, Richard Njouom, Ponsiano Ocama, Alisa Pedrana, Rosanna Ŵ. Peeling, Amulya Reddy, Jilian A. Sacks, Shiv Kumar Sarin, Yusuke Shimakawa, Marcela Silva, Pavlo Skala, Simon D. Taylor‐Robinson, Alexander Thompson, Mark Thursz, Alfred Tonganibeia, Jack Wallace, James Ward, Fernando Herz Wolff, Peter Vickerman, Johnny Yau - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 540

  5. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

    Authors: , , , , , , , , , , , , , , , - Gut 2019 cited by 279

  6. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pau Sancho‐Bru, Philippe Mathurin, Shinji Furuya, Carolin Lackner, Ivan Rusyn, Vijay H. Shah, Mark Thursz, Jelena Mann, Matías A. Ávila, Ramon Bataller - Nature Communications 2019 cited by 203

  7. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Trépo, Christophe Moreno, Alexandre Louvet, Philippe Mathurin - Journal of Hepatology 2024 cited by 136

  8. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota

    Authors: , , , , , , , , , , - Gastroenterology 2018 cited by 193

  9. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2017 cited by 226

  10. PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 110

  11. Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo—a Meta-analysis of Individual Data From Controlled Trials

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 232

  12. The role of neutrophils in alcohol-related hepatitis

    Authors: , , , - Journal of Hepatology 2023 cited by 55

  13. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

    Authors: , , , , , , , , , , - Nature Communications 2018 cited by 225

  14. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa

    Authors: , , , , , , , , , , , , , , , , - Gut 2015 cited by 365

  15. Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2014 cited by 287

  16. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sylvie Naveau, Pascal Perney, Munir Pirmohamed, Helmut K. Seitz, Michael Soyka, Felix Stickel, Andrew Thompson, Mark Thursz, Eric Trépo, Timothy R. Morgan, Devanshi Seth - Journal of Hepatology 2021 cited by 80

  17. Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip S. Tsao, Stephen R. Atkinson, Abbas Dehghan, Ioanna Tzoulaki, M. Arfan Ikram, Karl‐Heinz Herzig, Marjo‐Riitta Järvelin, Behrooz Z. Alizadeh, Christopher J. O’Donnell, Danish Saleheen, Benjamin F. Voight, Kyong‐Mi Chang, Mark Thursz, Paul Elliott, the VA Million Veteran Program, Zuhair K. Ballas, Sujata Bhushan, Edward J. Boyko, David Cohen, John Concato, Michaela Aslan, Hongyu Zhao, Joseph I. Constans, Louis J. Dell’Italia, Joseph Fayad, Ronald Fernando, Hermes Flórez, Melinda A. Gaddy, Saib Gappy, Gretchen Gibson, Michael Godschalk, Jennifer A. Greco, Samir Gupta, Salvador Gutierrez, Kimberly Hammer, Mark B. Hamner, John B. Harley, Adriana M. Hung, Mostaqul Huq, Robin A. Hurley, Pran Iruvanti, Douglas Ivins, Frank J. Jacono, Darshana Jhala, Laurence S. Kaminsky, Jon B. Klein, Suthat Liangpunsakul, Jack Lichy, Jennifer Moser, Grant D. Huang, Sumitra Muralidhar, Stephen Mastorides, Roy O. Mathew, Kristin Mattocks, Rachel McArdle, Paul N. Meyer, Laurence J. Meyer, Jonathan P. Moorman, Timothy R. Morgan, Maureen Murdoch, Olaoluwa Okusaga, Krisann K. Oursler, Nora Ratcliffe, Michael Rauchman, R. Brooks Robey, George Ross, Richard J. Servatius, Satish Sharma, Scott E. Sherman, Elif Sonel and 35 more - Nature Communications 2021 cited by 129

  18. Disruption of gut barrier integrity and host–microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus

    Authors: , , , , , , , , , , , - Gut Microbes 2024 cited by 48

  19. Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 62

  20. Requirements for global elimination of hepatitis B: a modelling study

    Authors: , , , , , , - The Lancet Infectious Diseases 2016 cited by 381

  21. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection

    Authors: , , , , , - AIDS 2017 cited by 227

  22. Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces

    Authors: , , , , , , , , - Analytical Chemistry 2016 cited by 184

  23. CD14 + CD15 − HLA-DR − myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure

    Authors: , , , , , , , , , , , , , , - Gut 2017 cited by 159

  24. The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2018 cited by 103